Coverage of "NovoCure" on cryptobo.eu: the stories and the context behind them.
NovoCure's shares jumped 28% after a record $183.6 million revenue quarter and an optimistic 2026 forecast. Positive EBITDA and strong demand fueled the stock rally.
